Neuroactive Thiazoline Compounds Modulating Calcium Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective solutions for modulating calcium release in mammals, which is crucial for treating disorders associated with calcium dysregulation, such as those affecting intracellular calcium stores and cell surface receptors.
Innovation Solution
Compounds with specific structures, represented by formulas involving various functional groups, are administered to modulate calcium release by binding to cellular proteins like G-protein receptors, thereby influencing calcium uptake or release in intracellular stores.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to treat calcium dysregulation disorders, then treatment effectiveness is insufficient, but no effective solution currently exists
Solution Approach 1:
The patent modifies the chemical structure of thiazoline compounds by changing parameters such as substituting hydrogen atoms with halogen atoms (fluorine, chlorine, bromine, or iodine) at specific positions (R1, R2, R3, R4a, R4b, R4c, or R4d). These structural parameter changes enhance the compounds' ability to bind to G-protein coupled receptors and modulate calcium release, thereby improving treatment effectiveness for calcium dysregulation disorders.
Solution Approach 2:
The patent creates composite molecular structures by combining the thiazoline core scaffold with various functional groups and substituents (halogen atoms, alkyl groups, heteroaryl groups, etc.). This composite approach allows the molecule to simultaneously interact with multiple target proteins including G-protein coupled receptors, ryanodine receptors, and IP3 receptors, thereby achieving versatile modulation of calcium release pathways.
2Reliability
If thiazoline compounds with specific structures are administered, then calcium release modulation is achieved, but the complexity of compound structure increases
Solution Approach 1:
The patent divides the complex thiazoline compound into distinct functional segments: a core thiazoline scaffold and multiple substitutable positions (R1-R4d) that can be independently modified. This segmentation allows systematic exploration of structure-activity relationships by varying individual substituents while maintaining the active core structure, thereby managing complexity through modular design.
Solution Approach 2:
The thiazoline compound structure is designed with universal binding capability across multiple calcium-related targets. The core structure serves multiple functions: binding to G-protein coupled receptors, modulating ryanodine receptors, and influencing IP3 receptor activity. This multi-functionality reduces the need for entirely different molecular structures for different mechanisms, thereby managing overall complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds effectively modulate calcium release in mammalian cells, including dorsal root ganglion cells, offering potential therapeutic benefits for disorders related to calcium dysregulation.
Implementation Method 1
Compounds with specific structures, represented by formulas involving various functional groups, are administered to modulate calcium release by binding to cellular proteins like G-protein receptors
Data Source
AI summary
In one aspect, the invention relates to compounds having a general structure: and methods of using same to modulate calcium release. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.